PACTR201802002998973已完成未知
The use of Milrinone versus conventional treatment for the management of life-threatening bronchial asthma
dramrsobhy0 个研究点目标入组 50 人开始时间: 2018年1月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 50 Year(s)（—）
- 性别
- All
入选标准
- •patients ranging age 18-50 years old arriving at the emergency room with life-threatening asthma according to the criteria of the British Guideline on the management of asthma 2008, revised October 2014. Life-threatening asthma is defined as any one or more of the following criteria:
- •¿PEF <33% best or predicted
- •¿SpO2 <92%
- •¿PaO2 <8 kPa (60 mm Hg)
- •¿Normal PaCO2 (4.6-6.0 kPa) (35-45 mm Hg)
- •¿Silent chest
- •¿Poor respiratory effort
- •¿Arrhythmia
- •¿Exhaustion, altered conscious level
- •¿Hypotension
排除标准
- •¿patientes with pre-existing heart failure, hypotensive patients, stenotic or obstructive valvular disease or other outlet obstruction, and patients with pre-existing arrhythmia
研究者
相似试验
已完成
3 期
Comparison of the effect of milrinone and dobutamine on pulmonary hypertensioPulmonary hypertension.Other secondary pulmonary hypertensionI27.2IRCT20211102052941N1Esfahan University of Medical Sciences38
已完成
3 期
Milrinone for Free Flap SurgeryACTRN12605000640606Department of Anaesthesia, St Vincent's Hospital Melbourne100
进行中（未招募）
不适用
Administration of the approved drug milrinone via venous access to treat and to prevent vasospasmSAB-induced vasospasmEUCTR2009-016620-32-ATDept. of Neurological Surgery, Medical University of Vienna
招募中
不适用
effect of nebulized milrinone and intravenous milrinone in patients with pulmonary hypertentioI27.2Pulmonary HTN.Other secondary pulmonary hypertensionIRCT20201104049266N1Ahvaz University of Medical Sciences16
尚未招募
Unknown
Milrinone versus dobutamine as supportive agent for right ventricular dysfunction after cardiopulmonary bypass: a prospective randomized comparative studyJPRN-UMIN000054149Mansoura university hospitals54